Related Experiment Video
Updated: Nov 6, 2025
Author Spotlight: Detection and Treatment of Helicobacter pylori Infection
Published on: July 28, 2023
Treatment Approach of Refractory Helicobacter pylori Infection: A Comprehensive Review
Pedro Cortés1, Alfred D Nelson1, Yan Bi1
1Mayo Clinic, Jacksonville, FL, USA.
Helicobacter pylori (H. pylori) infection is common worldwide and increasingly difficult to treat due to antibiotic resistance. This review covers risk factors, treatments, and new therapies for refractory H. pylori infections.
Area of Science:
- Gastroenterology
- Infectious Diseases
- Microbiology
Background:
- * *Helicobacter pylori* (*H. pylori*) is a prevalent global infection.
- * Associated with various gastrointestinal and extra-gastrointestinal conditions, including peptic ulcer disease and bleeding.
- * Rising incidence of refractory *H. pylori* infections is linked to antibiotic resistance and treatment challenges.
Purpose of the Study:
- * To review current understanding of refractory *H. pylori* infections.
- * To discuss risk factors contributing to treatment failure.
- * To explore current and emerging therapeutic strategies.
Main Methods:
- * Comprehensive literature review.
- * Analysis of risk factors for refractory infections.
- * Evaluation of established and novel treatment modalities.
Main Results:
- * Antibiotic resistance in *H. pylori* is a significant and growing concern.
- * Non-adherence and proton pump inhibitor (PPI) inefficacy contribute to treatment failures.
- * Refractory infections necessitate updated treatment guidelines and novel approaches.
Conclusions:
- * Refractory *H. pylori* poses a substantial clinical challenge.
- * Management requires careful consideration of risk factors and adherence.
- * Ongoing research into new therapies is crucial for improving patient outcomes.
More Related Videos
05:23Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
04:56Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis
Published on: May 16, 2025
Related Concept Videos
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
01:26Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
01:23Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
01:30Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
01:13Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...